|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Compliance, legal and regulatory | |||||
| Share based payments | |||||
| Revenue from customers | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net: | |||||
| R&D tax incentive | |||||
| Foreign exchange gains/(losses) | |||||
| Interest expense | |||||
| Interest income | |||||
| Change in fair value of convertible rights | |||||
| Change in fair value of warrant liabilities | |||||
| Warrant issuance costs | |||||
| Loss on extinguishment | |||||
| ELOC commitment fee | |||||
| Share of earnings (loss) of joint venture | |||||
| Total other income/(expenses), net | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive income/(loss): | |||||
| Currency translation adjustment, net of tax | |||||
| Total comprehensive loss | |||||
| Net loss per share: Basic (in USD per share) | |||||
| Net loss per share: diluted (in USD per share) | |||||
| Weighted average number of shares outstanding, basic (in shares) | |||||
| Weighted average number of shares outstanding, diluted (in shares) | |||||
Loading...